{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-149822","form_type":"8-K","ticker":"ANTX","cik":"0001880438","company_name":"AN2 Therapeutics, Inc.","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.230273+00:00","generated_at":"2026-05-15T06:49:29.739202+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AN2 Therapeutics enters $80M ATM offering with Jefferies; prior ATM terminated","bullets":["Entered into Open Market Sale Agreement with Jefferies to sell up to $80M of common stock at market prices.","Jefferies receives up to 3.0% commission; offering may be terminated by either party on 10 days' notice.","Terminated prior TD Cowen ATM under which 2,502,000 shares were sold for aggregate $20,016,251.","Effective April 9, 2026; no shares have been sold yet under new agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-149822","json":"https://secwatch.observer/filing/0001193125-26-149822.json","markdown":"https://secwatch.observer/filing/0001193125-26-149822.md","text":"https://secwatch.observer/filing/0001193125-26-149822.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526149822/0001193125-26-149822-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526149822/d127053d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:49:29.739202+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}